Health Condition 1: B354- Tinea corporis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically as well as KOH and mycological culture positive cases of Quba (tinea corporis and cruris). Patients who provide written informed consent to participate and willing to adhere to the protocol.
Exclusion criteria
Exclusion criteria: Pregnant and breastfeeding women. Patients suffering from serious systemic illnesses. Patients diagnosed with other dermatological conditions, such as eczema, psoriasis which may mimic or overlap with Quba. Other type of tinea. Patients with secondary bacterial infection (e.g., pyoderma) over the fungal lesions. Patients who were on antifungal or steroid therapy in the last week before entry in study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in KOH wet mount test Change in mycological culture Change in pruritus measured on VAS Change in erythema, peripheral raised margin with central clearing, and diameter of lesions (in cm) measured on Likert ScaleTimepoint: baseline, 7 day, 14 day, 28 day, 42 day and 60 day | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Dermatology Life Quality Index (DLQI) Change in Investigator s Static Global Assessment Clinical photographyTimepoint: baseline, 28 day and 60 day | — |
Countries
India
Contacts
Mahayogi Guru Gorakhnath Ayush University Gorakhpur